chartexchange

Eli Lilly’s Weight-Loss Pill Shows Sleep Apnea Benefits. Can It Gain on Novo?

Barron's | Nov 9, 2026 2:27 PM EST

Lilly plans to seek FDA approval for Foundayo to treat sleep apnea, potentially giving its weight-loss pill an edge over Novo Nordisk’s oral Wegovy.

Read original article